Synthesis, cytostatic and anti-HCV activity of 6-(N-substituted aminomethyl)-, 6-(O-substituted hydroxymethyl)- and 6-(S-substituted sulfanylmethyl)purine nucleosides. 2008

Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
Institute of Organic Chemistry and Biochemistry, v.v.i., Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.

An efficient and facile synthesis of a large series of diverse 6-(N-substituted aminomethyl)-, 6-(O-substituted hydroxymethyl)- and 6-(S-substituted sulfanylmethyl)purine nucleosides (55 examples of both ribo- and 2'-deoxyribonucleosides), aimed at identifying novel homologues of natural nucleosides, was developed. The key transformation involved nucleophilic substitutions of Tol-protected 6-(mesyloxymethyl)purine nucleosides by primary or secondary amines, alcoholates or thiolates. While the 2'-deoxyribonucleosides were inactive, the ribonucleosides exerted considerable cytostatic effects and some anti-HCV activity with low selectivity.

UI MeSH Term Description Entries
D008698 Mesylates Organic salts or esters of methanesulfonic acid. Mesilate,Methanesulfonates,Mesilates,Mesylate,Methylenesulfonates
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006900 Hydroxylation Placing of a hydroxyl group on a compound in a position where one did not exist before. (Stedman, 26th ed) Hydroxylations
D000586 Amination The creation of an amine. It can be produced by the addition of an amino group to an organic compound or reduction of a nitro group. Aminations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013457 Sulfur Compounds Inorganic or organic compounds that contain sulfur as an integral part of the molecule. Sulfur Compound,Compound, Sulfur,Compounds, Sulfur

Related Publications

Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
July 2008, Archives of pharmacal research,
Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
July 2010, Bioorganic & medicinal chemistry,
Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
September 2005, Journal of medicinal chemistry,
Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
February 2014, Journal of medicinal chemistry,
Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
December 2010, European journal of medicinal chemistry,
Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
January 1984, Revista espanola de oncologia,
Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
November 1969, Journal of medicinal chemistry,
Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
December 2007, Bioorganic & medicinal chemistry letters,
Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
May 1983, Yao xue xue bao = Acta pharmaceutica Sinica,
Peter Silhár, and Michal Hocek, and Radek Pohl, and Ivan Votruba, and I-Hung Shih, and Eric Mabery, and Richard Mackman
July 1994, Die Pharmazie,
Copied contents to your clipboard!